Treating systemic diseases via the lung

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 14, Issue , 2001, Pages S51-S58

  Sanjar, S ^a   Matthews, J ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Asthma; Treatment

Indexed keywords

ADENOSINE A1 RECEPTOR AGONIST; ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; APTAMER; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; IMMUNOGLOBULIN E ANTIBODY; MORPHINE; SEROTONIN AGONIST; SILDENAFIL; VACCINE;

DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG METABOLISM; DRUG TISSUE LEVEL; HUMAN; LUNG CIRCULATION; LUNG DISEASE; REVIEW; SYSTEMIC DISEASE;

ADMINISTRATION, INHALATION; ANIMALS; BIOLOGICAL AVAILABILITY; DRUG DELIVERY SYSTEMS; DRUG THERAPY; HUMANS; LUNG; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE;

EID: 0035111927     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/08942680150506349     Document Type: Review

References (36)

1. Tennis anyone? The lungs as a new court for systemic therapy
2. Delivery of biotherapeutics by inhalation aerosol
3. Pharmacology and pharmacokinetics of topical corticosteroid derivatives used for asthma therapy
4. Control of asthma by aerosols
5. Optimizing drug delivery from metered-dose inhalers
6. The lung deposition of salbutamol, directly labelled with technetium-99m, delivered by pressurised metered-dose and dry, powder inhalers
7. Effect of relative humidity on particle size distribution from Turbuhaler®
8. Drug delivery via aerosol systems: Concept of "aerosol inhaled.
9. Lung deposition of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction
10. Peak inspiratory, flow through Turbuhaler™ in acute asthma
11. Peak inspiratory flow through Turbuhaler™ in chronic obstructive airways disease
12. Comparative measurement of lung deposition of inhaled fine particles in normal subjects and patients with obstructive airway disease
13. Human cigarette smoking: Effects of puff and inhalation parameters on smoke exposure
14. Inhalation route for administration of systemic drugs
15. New inhalation agents in paediatric anaesthesia
16. Sumatriptan nasal spray in the acute treatment of migraine: A review of clinical studies
17. Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial
18. Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjects
19. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: A double-blind placebo-controlled trial
20. Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus
21. The lung as an alternative route of delivery for insulin in controlling postprandial glucose levels in patients with diabetes
22. The pulmonary absorption of aerosolized and intratracheally instilled rhG-CSF and monoPEGylated rhG-CSF
23. Pulmonary absorption of recombinant methionyl human granulocyte colony stimulating factor (r-huG-CSF) after intratracheal instillation to the hamster
24. Pulmonary absorption of recombinant human granulocyte colony-stimulating factor (rhG-CSF) after intratracheal administration to rats
25. Absorption of recombinant human granulocyte colony-stimulating factor (rhG-CSF) from rat nasal mucosa
26. The influence of regional deposition on the pharmacokinetics of pulmonary-delivered human growth hormone in rabbits
27. Minimal dose of aerosolized interferon-alpha in human subjects: Biological consequences and side-effects
28. Effects of aerosolized interferon-α in patients with pulmonary tuberculosis
29. Interleukin-2 by inhalation: Local therapy for metastatic renal cell carcinoma
30. Species comparison of drug absorption from the lung after aerosol inhalation or intratracheal injection
31. Permeability of the respiratory tract to different-sized macromolecules after intratracheal instillation in young and adult rats
32. Analysis of drug permeation across Caco-2 monolayer: Implication for predicting in vivo drug absorption
33. In vitro permeability, of eight beta-blockers through Caco-2 monolayers utilizing liquid chromatography/electrospray ionization mass spectrometry
34. Cell lines of pulmonary and non-pulmonary origin as tools to study the effects of house dust mite proteinases on the regulation of epithelial permeability
35. Use of alveolar cell monolayers of varying electrical resistance to measure pulmonary peptide transport
36. Effect of chitosan on epithelial permeability and structure